Latest Information Update: 12 Mar 2008
At a glance
- Originator Purdue University
- Developer Pharmacia Corporation; Purdue University
- Class Antineoplastics
- Mechanism of Action Electron transport complex I inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 05 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation